Efficacy of non‐invasive mechanical ventilation in the general ward in patients with chronic obstructive pulmonary disease admitted for hypercapnic acute respiratory failure and pH < 7.35: a feasibility pilot study

Internal Medicine Journal - Tập 45 Số 5 - Trang 527-537 - 2015
Sirio Fiorino1, Maria Letizia Bacchi Reggiani2, Eugenio Detotto1, Michele Battilana1, Elisa Borghi1, C. Denitto1, C. Dickmans1, B. Facchini1, R. Moretti1, S Parini1, Maria R. Testi1, A Zamboni1, A Cuppini1, Lara Pisani3, Stefano Nava3
1Unità Operativa di Medicina Interna Ospedale di Budrio (Bologna) Department of Internal Medicine Azienda Unità Sanitaria Locale di Bologna Bologna Italy
2Istituto di Cardiologia Azienda Ospedaliera Policlinico S. Orsola‐Malpighi Department of Specialist, Diagnostic, and Experimental Medicine School of Medicine University of Bologna Bologna Italy
3Terapia Intensiva Pneumologia S. Orsola Azienda Ospedaliera Policlinico S. Orsola‐Malpighi Department of Specialist, Diagnostic, and Experimental Medicine School of Medicine University of Bologna Bologna Italy

Tóm tắt

AbstractAimTo date non‐invasive (NIV) mechanical ventilation use is not recommended in chronic obstructive pulmonary disease (COPD) patients with acute respiratory failure (ARF) and pH < 7.30 outside a ‘protected environment’. We assessed NIV efficacy and feasibility in improving arterial blood gases (ABG) and in‐hospital outcome in patients with ARF and severe respiratory acidosis (RA) admitted to an experienced rural medical ward.MethodsThis paper is a prospective pilot cohort study conducted in the General Medicine Ward of Budrio's District Hospital. Two hundred and seventy‐two patients with ARF were admitted to our Department, 112, meeting predefined inclusion criteria (pH < 7.35, PaCO2 > 45 mmHg). Patients were divided according to the severity of acidosis into: group A (pH < 7.26), group B (7.26 ≤ pH < 7.30) and group C (7.30 ≤ pH < 7.35). ABG were assessed at admission, at 2–6 h, 24 h, 48 h and at discharge.ResultsGroup A included 55 patients (24 men, mean age: 80.8 ± 8.3 years), group B 31 (12 men, mean age: 80.3 ± 9.4 years) and group C 26 (15 men, mean age: 78.6 ± 9.9 years). ABG improved within the first hours in 92/112 (82%) patients, who were all successfully discharged. Eighteen per cent (20/112) of the patients died during the hospital stay, no significant difference emerged in mortality rate (MR) within the groups (23%, 16% and 8%, for groups A, B and C, respectively) and between patients with or without pneumonia: 8/29 (27%) versus 12/83 (14%). On multivariable analysis, only age and Glasgow Coma Scale had an impact on the clinical outcome.ConclusionIn a non‐‘highly protected’ environment such as an experienced medical ward of a rural hospital, NIV is effective not only in patients with mild, but also with severe forms of RA. MR did not vary according to the level of initial pH.

Từ khóa


Tài liệu tham khảo

10.1097/01.CCM.0000057906.89552.8F

10.1164/rccm.201201-0034OC

10.1513/pats.200709-148ET

10.1136/thx.50.7.755

10.1183/09031936.05.00085304

10.1093/ageing/afi211

10.1016/j.itjm.2010.06.002

10.1016/S0140-6736(00)02323-0

10.1136/thorax.55.10.819

10.1016/0021-9681(87)90171-8

10.1183/09031936.05.00034805

10.1378/chest.124.2.459

10.1016/j.ajem.2006.09.014

10.1002/jhm.2004

10.1164/ajrccm.163.1.ats1000

10.1136/thorax.57.3.192

Sulaiman MI, 2004, A survey of the use of non invasive positive pressure ventilation in critical care units in the United Kingdom, Am J Respir Crit Care Med, 169, A522

10.1136/thx.2010.153114

10.1378/chest.126.1.165

Cabrini L, 2012, Noninvasive ventilation outside the intensive care unit from the patient point of view: a pilot study, Respir Care, 57, 704, 10.4187/respcare.01474

10.1016/j.rmed.2006.04.013

10.1007/s00134-004-2320-7

10.1001/jamainternmed.2014.5430

10.1155/2014/976783

10.1513/AnnalsATS.201206-034OC

10.1097/CCM.0b013e31826ab4af

10.1164/rccm.201206-1101OC

Benhamou D, 1998, Mechanical ventilation in elderly patients, Monaldi Arch Chest Dis, 53, 547

10.1093/ageing/afr003

10.1378/chest.11-0957

10.4187/respcare.03294